Karyopharm Announces $30 Million Private Placement with RA Capital

Karyopharm Announces $30 Million Private Placement with RA Capital Accessibility StatementSkip Navigation NEWTON, Mass., March 24, 2026 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that it has entered into a securities purchase agreement with RA Capital Management for a private placement that is expected to result in gross proceeds of approximately $30 million before deducting placement agent fees an ...